Saturday, January 31, 2026

How Samsung’s 8.6-Generation OLED is Set to Dominate the EV Market in 2026

Samsung Display's CEO discusses growth in OLED technology, market strategies, and challenges at CES 2026, including automotive sector plans.

Market Watch: Analysts Predict Major Bitcoin Dip as Election Approaches

After Bitcoin's collapse to $59,000 due to...

BMW Selects Hankook’s iON evo SUV Tires as Original Equipment for Flagship EV

Hankook Tire will supply its iON evo SUV tires for BMW's iX electric SUV, enhancing performance with innovative technology.

Health

How a 2-Cent Sugar Tax Could Save $4.5 Billion in Healthcare Costs: California’s Bold Move

A sugar-sweetened beverage tax in California could cut obesity cases and save $4.5 billion in healthcare costs over ten years.

Unlocking Global Potential: ezCaretech’s AI-Driven Healthcare Solutions for Saudi Arabia

ezCaretech is expanding into the Middle East, focusing on Saudi Arabia, with innovative healthcare technology and global partnerships.

Celltrion’s Zymfentra: How This Breakthrough Drug is Driving Record Sales

Celltrion expects record sales driven by Zymfentra's success, expanding into new biosimilars and CDMO business for future growth.

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

Chinese Biotech’s Rise: What’s the Standard of Global Tech Trade?

Analysts at the JPMHC noted a shift in biotech, with firms resisting sales and China emerging as a tech transfer leader.
Latest

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

Man Finds Brain Aneurysm by Accident—Here’s What You Should Know

A man discovers a cerebral aneurysm during a check-up, highlighting the importance of early detection and advancements in treatment options.

Scorching Heat Raises Hidden Risk of Heart Attacks, Doctors Warn

South Korea faces a heat wave, increasing heat-related illnesses and myocardial infarction cases. Prompt treatment is crucial for survival.

Lost Your Voice for Over Two Weeks? It Could Be More Than a Cold

Persistent hoarseness may signal laryngeal cancer, especially in those over 60. Early diagnosis is vital for effective treatment.

70% of Suicide Survivors Stayed Safe with Ongoing Mental Health Support

A study shows that active management of depression in patients can significantly reduce suicidal behavior, urging expanded community care.

More People Turning Up the AC—and Getting Sick

A heatwave in South Korea raises health concerns linked to air conditioning, with symptoms resembling flu and COVID-19.

Crash Diets Could Be Crashing Your Bones, Doctors Warn

Extreme dieting can harm bone health, increasing osteoporosis risk, especially in women. Balanced nutrition and moderate exercise are essential.

Wegovy Gets Stronger: New Dose Promises Even More Weight Loss

Novo Nordisk's new high-dose Wegovy aims to enhance obesity treatment, with promising trial results and a strategic EU rollout planned.

Botox, Fillers, and Bone Surgery? The Surprising Ways People Are Chasing the Perfect V-Line

A well-defined jawline is key for a beautiful face, with many preferring a V-line for a smaller, more dimensional appearance.

K-pop Star HyunA Reveals the One Exercise That Changed Her Body

K-pop star HyunA shares her weight loss journey, emphasizing walking and diet while noting important exercise precautions.

As Wegovy and Mounjaro Soar, Korean Biotechs Seek a Slice of the Obesity Drug Market

South Korean firms are innovating in the GLP-1 obesity treatment market, developing unique drugs to compete with industry leaders.

This New Drug Could Stop Kidney Failure After Heart Surgery

Bilix receives MFDS approval for Phase 2a trial of Brixelle, targeting acute kidney injury in cardiac surgery patients.

Big Pharma Braces for $300 Billion Loss as Blockbuster Drug Patents Expire

Global pharma faces $300B losses from patent expirations, prompting a shift to multi-indication drugs and innovative therapies.

Rising Use of GLP-1 Drugs May Be Linked to Rare Pancreatitis Cases, Study Finds

Reports of acute pancreatitis linked to GLP-1 diabetes drugs surge in the UK, prompting investigations and conflicting academic findings.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.